SearchDictionaryMobileLogin

meturedepa (AB 132)

Subscribe to Selected New Research on meturedepa
3  relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: structure in Merck Index, 9th ed, #6031

Also Known As:
AB 132; NSC 51325; ethyl (bis(2,2-dimethyl-1-aziridinyl)phosphinyl)carbamate; (bis(2,2-dimethyl-1-aziridinyl)phosphinyl)carbamic acid, ethyl ester

Bio-Agent Context: Research Results

-
Heterocyclic Compounds: 23
-
1-Ring Heterocyclic Compounds
-
Azirines
-
Aziridines: 12
*
meturedepa: 3

Related Diseases

1. Bronchogenic Carcinoma
2. Neoplasms (Cancer)
10/01/1968 - "Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer"
Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Bronchogenic Carcinoma
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 44 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>